期刊
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 -, 期 -, 页码 -出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-023-01329-4
关键词
Fucoidan; Sulfated polysaccharide; Brown algae; Marine seaweed; Nanodrug delivery; Anticancer activity
Fucoidan, a sulfated marine seaweed obtained from brown algae, has attracted significant interest due to its various biological activities and potential applications in drug delivery systems. This polysaccharide has been extensively studied for its regenerative properties, wound healing capabilities, and as a drug delivery vehicle. However, the main challenge lies in the variability of fucoidan extraction from different species, harvesting methods, and climatic factors. This review provides a comprehensive overview of fucoidan's origin, chemical structure, physicochemical and biological properties, and its role in nanodrug delivery systems.
Fucoidan-a sulfated marine seaweed obtained from brown algae-has raised considerable interest in the scientific community over the last decade as it possesses a wide range of biological activities such as antioxidant, antiviral, anti-inflammatory, anticoagulant, antithrombotic, anticarcinogenic, and immunoregulatory. This polysaccharide finds application as a drug delivery vehicle due to its non-cytotoxicity, biocompatibility, and biodegradability. Besides, nano biomedical systems have used this marine alga for diagnostic and therapeutic purposes. Fucoidan has been extensively studied for use in regenerative medicines, in wound healing, and for sustained drug delivery due to its large biodiversity, cost-effectiveness, and mild procedures for extraction and purification. However, the main concern that limits its application is the variance in its batch-to-batch extraction owing to species type, harvesting, and climatic factors. The current review encloses a compendious overview of the origin, chemical structure, and physicochemical and biological properties of fucoidan and its significant role in nanodrug delivery systems. Special emphasis is given to the recent advances in the use of native/modified fucoidan, its combination with chitosan and metal ions for nanodrug delivery applications, especially in cancer treatment. Additionally, use of fucoidan in human clinical trials as a complementary therapeutic agent is also reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据